0000950103-16-012834.txt : 20160427 0000950103-16-012834.hdr.sgml : 20160427 20160427100616 ACCESSION NUMBER: 0000950103-16-012834 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20160427 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20160427 DATE AS OF CHANGE: 20160427 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Shire plc CENTRAL INDEX KEY: 0000936402 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-29630 FILM NUMBER: 161593741 BUSINESS ADDRESS: STREET 1: HAMPSHIRE INTL BUSINESS PARK STREET 2: CHINEHAM BASINGSTOKE CITY: HAMPSHIRE ENGLAND RG STATE: X0 ZIP: RG24 8EP BUSINESS PHONE: 441256894000 MAIL ADDRESS: STREET 1: HAMPSHIRE INTL BUSINESS PARK STREET 2: CHINEHAM BASINGSTOKE CITY: HAMPSHIRE ENGLAND RG STATE: X0 ZIP: RG24 8EP FORMER COMPANY: FORMER CONFORMED NAME: Shire Ltd. DATE OF NAME CHANGE: 20080523 FORMER COMPANY: FORMER CONFORMED NAME: Shire plc DATE OF NAME CHANGE: 20051125 FORMER COMPANY: FORMER CONFORMED NAME: SHIRE PHARMACEUTICALS GROUP PLC DATE OF NAME CHANGE: 19980302 8-K 1 dp65220_8k.htm FORM 8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

FORM 8-K 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): April 27, 2016

 

Shire plc

 

(Exact name of registrant as specified in its charter)
Jersey, Channel Islands

 

 

(State or other jurisdiction of incorporation)

 

0-29630   98-0601486
(Commission File Number)   (IRS Employer Identification No.)

 

5 Riverwalk, Citywest Business Campus, Dublin 

24, Republic of Ireland 

 

(Address of principal executive offices) (Zip code)

 

Registrant’s telephone number, including area code +353 1 429 7700 

 

(Former name or former address, if changed since last report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.):

 

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.f13e-4(c))
   
 

 

 

 
Item 8.01.Other Events

 

Shire plc have issued the press releases attached hereto as Exhibit 99.1 which is incorporated by reference herein.

 

Item 9.01.Financial Statements and Exhibits

 

(d) Exhibits. The following exhibit is filed herewith:

 

99.1 Press Release dated April 27, 2016
 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

SHIRE PLC

 

 

By: /s/ B Mordan
  Name: Bill Mordan
  Title: Company Secretary

Dated: April 27, 2016

 

 

 

 

 

EXHIBIT INDEX

 

Number Description
   
99.1 Press Release dated April 27, 2016

 

 

 

 EX-99.1 2 dp65220_ex9901.htm FORM 99.1

EXHIBIT 99.1

 

Press Release

www.shire.com 

  SL_rgb_lo_blue_pms3005 release.jpg

 

Holding(s) in Company

 

April 27, 2016 - Shire plc (LSE: SHP, NASDAQ: SHPG)

 

1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached: ii		 Shire plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights X
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached  
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments  
An event changing the breakdown of voting rights  
Other (please specify):    
3. Full name of person(s) subject to the
notification obligation: iii		 Susan Kilsby (Chairman of Shire plc and proxy holder)
4. Full name of shareholder(s)
 (if different from 3.):iv		 Shareholders appointing the Chairman of Shire plc as proxy
5. Date of the transaction and date on
which the threshold is crossed or
reached: v		 26 April 2016
6. Date on which issuer notified: 27 April 2016
7. Threshold(s) that is/are crossed or
reached: vi, vii		 3%
         

 

 

 

8. Notified details:
A: Voting rights attached to shares viii, ix

Class/type of
shares


if possible using
the ISIN CODE

 Situation previous
to the triggering
transaction		 Resulting situation after the triggering transaction
Number
of
Shares		 Number
of
Voting
Rights		 Number
of shares		 Number of voting
rights		 % of  voting rights x
Direct Direct xi Indirect xii Direct Indirect
Ordinary Shares of 5 pence each 21,375 21,375 21,375 21,375 20,351,927 0.0036% 3.4307%
JE00B2QKY057

 

B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial
instrument		 Expiration
date xiii		 Exercise/
Conversion Period xiv		 Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.		 % of voting
rights
         

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial
instrument		 Exercise price Expiration date xvii Exercise/
Conversion period xviii

Number of voting rights instrument refers to

% of voting rights xix, xx

        Nominal Delta
   

 

Total (A+B+C)
Number of voting rights Percentage of voting rights
20,373,302 3.4343%

 

 

 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: xxi

 

 

 

 

  

 

Proxy Voting:
10. Name of the proxy holder: Susan Kilsby (Chairman of Shire plc)
11. Number of voting rights proxy holder will cease
to hold:		 20,351,927
12. Date on which proxy holder will cease to hold
voting rights:		 At the conclusion of the Annual General Meeting to be held on 28 April 2016, or any adjournment thereof

 


13. Additional information:		 The number of indirect voting rights represents the maximum number of discretionary proxy votes held by the Chairman of Shire plc pursuant to proxies received in respect of the resolutions to be considered by shareholders at the Annual General Meeting to be held on 28 April 2016. The voting rights will expire immediately upon the conclusion of the Annual General Meeting, or any adjournment thereof. The appointment of a proxy shall not preclude a shareholder of Shire plc from attending and voting in person at the Annual General Meeting.   
 
14. Contact name: Bill Mordan (Company Secretary of Shire plc)
15. Contact telephone number: +1 781 482 9393

 

 

 

For further information please contact:

 

Investor Relations    
Sarah Elton-Farr seltonfarr@shire.com +44 1256 894157

 

NOTES TO EDITORS

 

Shire enables people with life-altering conditions to lead better lives.

 

Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.

 

We focus on providing treatments in Rare Diseases, Neuroscience, Gastrointestinal and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmics.

 

www.shire.com

 

 

 

 GRAPHIC 3 image_002.jpg GRAPHIC begin 644 image_002.jpg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